A MULTICENTER DOUBLE BLIND RANDOMIZED SINGLE DOSE ACTIVE-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF SYNTHETIC SURFACTANT (CHF 5633) IN COMPARISON TO PORCINE SURFACTANT (PORACTANT ALFA CUROSURF?) IN THE TREATMENT OF PRETERM NEONATES WITH RESPIRATORY DISTRESS SYNDROME.
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this study is to compare a new surfactant (CHF 5633) investigational drug with a similar standard product on the market also manufactured by CHIESI, Poractant Alfa.
Description
The purpose of this study is to compare a new surfactant (CHF 5633) investigational drug with a similar standard product on the market also manufactured by CHIESI, Poractant Alfa.
Details
| Condition | neonatal respiratory distress syndrome |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX6275 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.